| Literature DB >> 29143131 |
Lisa Johansson1,2, Daniel Sundh1, Martin Nilsson1,3, Dan Mellström1,4, Mattias Lorentzon5,6.
Abstract
Studies investigating prevalent vertebral fracture (VF) diagnosed using densitometry-based VF assessment (VFA) and associations with physical function, assessed by performance-based measures, are lacking. In this population-based study of 1027 older women, we found that prevalent VF, identified by VFA, was associated with inferior physical health, back pain and inferior physical function.Entities:
Keywords: Back pain; HRQL; Physical function; Vertebral fracture; Vertebral fracture assessment
Mesh:
Year: 2017 PMID: 29143131 PMCID: PMC5758688 DOI: 10.1007/s00198-017-4296-5
Source DB: PubMed Journal: Osteoporos Int ISSN: 0937-941X Impact factor: 4.507
Characteristics of older women without VFA-diagnosed vertebral fracture (VF) and increasing number of vertebral fractures
| No VF | One VF | Two VFs | More than two VFs |
| |
|---|---|---|---|---|---|
|
|
|
|
| ||
| Age, years | 77.7 ± 1.6 | 77.8 ± 1.4 | 77.8 ± 1.4 | 77.9 ± 1.4 | 0.690 |
| Height (cm) | 162.4 ± 5.9 | 161.4 ± 5.3§ | 161.6 ± 6.1 | 159.8 ± 4.9* |
|
| Height at age 25 (cm) | 165.6 ± 5.6i | 165.5 ± 4.9 | 165.2 ± 5.6 | 166.3 ± 4.8 | 0.872 |
| Weight (kg) | 68.5 ± 11.8 | 67.8 ± 10.9 | 71.2 ± 14.5 | 66.3 ± 11.0 | 0.193 |
| Body mass index (kg/m2) | 26.0 ± 4.3 | 26.0 ± 3.8 | 27.3 ± 5.1 | 25.9 ± 3.9 | 0.187 |
| Physical activity (PASE) | 110.3 ± 53.7j | 101.7 ± 45.1o | 110.9 ± 53.4q | 100.5 ± 69.3 | 0.181 |
| Fall accident last year, % ( | 29.7 (223) | 33.0 (64) | 39.3 (22) | 37.0 (10) | 0.366 |
| Calcium intake (mg/day) | 695.5 ± 386.1k | 707.2 ± 414.4 | 708.4 ± 389.3 | 897.9 ± 434.0 | 0.075 |
| Self-reported fracture, % ( | 34.7 (259)k | 39.4 (76)o | 60.7 (34) | 66.7 (18) |
|
| Smoking, % ( | 6.6 (50) | 6.2 (12) | 3.6 (2) | 7.4 (2) | 0.827 |
| Alcohol, % ( | 0.1 (1)l | 0.0 (0) | 0.0 (0) | 0.0 (0) | 0.946 |
| Pharmacological treatment | |||||
| Glucocorticoids, previous use, % ( | 2.3 (17)m | 2.1 (4)p | 7.3 (4)q | 7.7 (2)r | 0.060 |
| Glucocorticoids, current | 2.4 (18) | 3.1 (6) | 5.4 (3) | 11.1 (3) |
|
| Osteoporosis medication, previous use % ( | 13.1 (98) | 19.6 (38) | 29.1 (16)q | 63.0 (17) |
|
| Osteoporosis medication, current use % ( | 0.1 (36) | 5.2 (10) | 17.9 (10) | 22.2 (6) |
|
| Medical history | |||||
| Parkinson’s disease, % ( | 0.5 (4) | 0.5 (1) | 0.0 (0) | 3.7 (1) | 0.179 |
| Rheumatoid Arthritis, % ( | 3.3 (25)n | 4.6 (9) | 1.8 (1) | 0.0 (0) | 0.513 |
| Stroke, % ( | 8.3 (62) | 7.2 (14) | 3.6 (2) | 25.9 (7) |
|
| Hypothyroidism, % ( | 13.3 (99)k | 10.9 (21)o | 19.6 (11) | 11.1 (3) | 0.384 |
| Osteoporosis, % ( | 14.4 (108)l | 23.2 (45) | 32.1 (18) | 70.4 (19) |
|
| Hypertension, % ( | 50.4 (378) | 53.6 (104) | 70.4 (27) | 70.4 (19) | 0.187 |
| Cataract, % ( | 42.5 (319) | 47.4 (92) | 53.6 (30) | 48.1 (13) | 0.281 |
| Cancer, % ( | 19.3 (145) | 17.5 (34) | 12.5 (7) | 25.9 (7) | 0.440 |
Values are presented as mean ± standard deviation for continuous variables and as percentage and number for categorical variables
PASE Physical Activity Scale for the Elderly
aAfter 50 years of age, fracture of hip, vertebra, lower arm/wrist, clavicula/shoulder, proximal humerus, costae, femur, knee, lower leg, ancle/foot/toe, hand/finger
bSmoking at any time during the last 6 months
c21 or more units per week (as for FRAX)
dAt least 3 months of their life
eUsage based on the last 30 days
fAny usage of bisphosphonate, zoledronic acid, strontiumranelat, parathyroid hormone, denosumab
gBisphosphonates and denosumab last month
hSelf-reported from the question “Have the doctor told you that you have osteoporosis?”
i688
j747
k746
l749
m726
n748
o193
p188
q55
r26
sContinuous variables one way ANOVA followed by least significant difference post hoc test
tCategorical variables χ 2 test, Pearson’s chi-square. Significance was defined by a p value < 0.05 and significant values are presented in bold
§One VF vs. no VF
*More than two VFs vs. no VF
Fig. 1The number of vertebral fractures presented according to different types of fractures and vertebral level (T4–L4)
Health-related quality of life, back pain and physical function in relation to number of vertebral fractures (VF)
| No VF | VF (any) |
| One VF | Two VF | More than two VFs | ANOVAA
| |
|---|---|---|---|---|---|---|---|
| SF-12 | |||||||
| PCS12 | 46.2 ± 10.5c | 43.5 ± 11.3j |
| 43.7 ± 11.1§o | 45.0 ± 10.6 | 39.0 ± 13.9*^#w |
|
| MCS12 | 54.3 ± 8.5c | 54.7 ± 9.1j | 0.543 | 54.5 ± 8.9o | 55.4 ± 9.4 | 54.1 ± 9.7w | 0.810 |
| Back pain, % (n) | 59.9 (449) | 69.0 (191) |
| 67.5 (131) | 69.6 (39) | 77.8 (21) |
|
| Function | |||||||
| OLS (s) | 15.3 ± 10.4d | 13.5 ± 10.3k |
| 13.0 ± 10.1p | 15.9 ± 11.1t | 11.8 ± 9.2× | 0.051 |
| TUG (s) | 8.5 ± 2.6e | 9.1 ± 3.2j |
| 9.1 ± 3.4§o | 8.4 ± 2.2 | 10.3 ± 3.6*^#w |
|
| TUG manual (s) | 10.1 ± 2.6f | 10.5 ± 2.8l |
| 10.5 ± 2.7q | 10.0 ± 2.3 | 12.2 ± 3.8*^#y |
|
| Walking speed, (m/s) | 1.29 ± 0.23g | 1.23 ± 0.26j |
| 1.23 ± 0.25o | 1.29 ± 0.24 | 1.10 ± 0.28*^#w |
|
| 30-s chair stand test, ( | 11.4 ± 3.4h | 10.7 ± 3.1m |
| 10.6 ± 3.1§r | 11.2 ± 3.1u | 10.5 ± 3.6z |
|
| Grip strength (kg) | 13.4 ± 5.2i | 13.1 ± 5.8n | 0.358 | 13.0 ± 5.6s | 13.8 ± 6.1v | 12.1 ± 6.2w | 0.481 |
Results are presented as mean ± standard deviation for continuous variables and as percentage and number for categorical variables
PCS Physical Component Summary, MCS Mental Component Summary, OLS one-leg standing, TUG Timed Up and Go, TUG manual Timed Up and Go with a glass of water in one hand. Maximum grip strength is presented for the dominant hand
AOne way ANOVA, followed by least significant difference post hoc test
aIndependent samples t test
bχ2 test
c749
d613
e747
f735
g745
h710,
i729
j275
k213
l267
m256
n270
o193
p155
q188
r182
s189
t41
u53
v55
w26
x17
y23
z21
§One VF vs. no VF
*More than two VFs vs. no VF
^More than two VFs vs. one VF
#More than two VFs vs. two VFs. Significance was defined by a p value < 0.05 and significant values are presented in bold
Health-related quality of life, back pain and physical function in relation to severity of VF
| No VF | Mild VF | Moderate VF | Severe VF | ANOVAA
| |
|---|---|---|---|---|---|
| SF-12 | |||||
| PCS12 | 46.2 ± 10.5a | 43.8 ± 10.9§ | 45.3 ± 10.6k | 40.2 ± 12.6*^# |
|
| MCS12 | 54.3 ± 8.5a | 54.2 ± 8.3h | 55.1 ± 9.3k | 54.7 ± 10.1 | 0.832 |
| Back pain, % ( | 59.9 (449) | 65.4 (70) | 63.6 (68) | 84.1 (53) |
|
| Function | |||||
| OLS (s) | 15.3 ± 10.4b | 12.7 ± 9.9§h | 15.2 ± 10.5l | 11.8 ± 10.4*o |
|
| TUG (s) | 8.5 ± 2.6c | 8.5 ± 2.2 | 8.8 ± 2.4i | 10.5 ± 5.0*^#p |
|
| TUG manual (s) | 10.1 ± 2.6d | 10.5 ± 2.8i | 10.2 ± 2.6m | 11.1 ± 3.0*#q |
|
| Walking speed, (m/s) | 1.29 ± 0.23e | 1.25 ± 0.22 | 1.26 ± 0.25i | 1.13 ± 0.30*^#p |
|
| 30-s chair stand test ( | 11.4 ± 3.4f | 10.7 ± 3.2§j | 11.0 ± 3.1n | 10.2 ± 2.9*r |
|
| Grip strength, (kg) | 13.4 ± 5.2g | 13.1 ± 6.0k | 13.6 ± 5.5i | 12.0 ± 5.8s | 0.216 |
Results are presented as mean ± standard deviation for continuous variables and as percentage and number for categorical variables
PCS Physical Component Summary, MCS Mental Component Summary, OLS one-leg standing, TUG Timed Up and Go, TUG manual Timed Up and Go with a glass of water in one hand. Maximum grip strength is presented for the dominant hand
AOne way ANOVA, followed by least significant difference post hoc test
B χ 2 test was used. Significance was defined by a p value < 0.05 and significant values are presented in bold
a749
b613
c747
d735
e745
f710
g729
h90
i106
j102
k105
l79
m104
n101
o44
p62
q57
r53
s59
§Mild VF vs. no VF
*Severe VF vs. no VF
^Severe VF vs. mild VF
#Severe VF vs. moderate VF
Association between health-related quality of life and physical function and vertebral fracture (VF) number and severity in older women
| VF (no/yes) | Number of VF | Severity of VF | ||||
|---|---|---|---|---|---|---|
| β |
| β |
| β |
| |
| SF-12 | ||||||
| PCS | − 0.079 |
| − 0.083 |
| − 0.091 |
|
| MCS | 0.012 | ns | 0.015 | ns | 0.019 | ns |
| Functiona | ||||||
| OLS (s) | − 0.042 | ns | − 0.027 | ns | − 0.034 | ns |
| TUG, (s) | 0.067 |
| 0.067 |
| 0.109 |
|
| TUG manual (s) | 0.041 | ns | 0.059 |
| 0.043 | ns |
| Walking speed, (m/s) | − 0.071 |
| − 0.078 |
| − 0.096 |
|
| 30-s chair stand test ( | − 0.075 |
| − 0.057 | ns | − 0.075 |
|
| Grip strength (kg) | 0.008 | ns | 0.007 | ns | − 0.001 | ns |
Linear regression models were used to investigate associations between HRQL and physical function, as dependent variables, and VF and covariates (age, weight, height, fall accident last year, Parkinson’s disease, rheumatoid arthritis, stroke, hypothyroidism, hypertension, cataract, cancer, asthma/bronchitis/emphysema, diabetes, smoking, alcohol, scoliosis, self-reported fracture), as independent variables. The results are presented as standardized β coefficients (SD change in the dependant variable per SD change in the independent variable) and p values. Significance was defined by a p value < 0.05 and significant values are presented in bold
PCS Physical Component Summary, MCS Mental Component Summary, OLS one-leg standing, TUG Timed Up and Go, TUG manual Timed Up and Go with a glass of water in one hand. Maximum grip strength is presented for the dominant hand
aPASE included as covariate and self-reported fracture not included
Association between back pain and vertebral fracture (VF) number and severity in older women
| VF (no/yes) | Number of VF | Severity of VF | |
|---|---|---|---|
| OR (95% CI) | OR (95% CI) | OR (95% CI) | |
| Back pain, |
|
|
|
Logistic regression models were used to investigate associations between back pain, as dependent variable, and VF and covariates (age, weight, height, fall accident last year, Parkinson’s disease, rheumatoid arthritis, stroke, hypothyroidism, cataract, cancer, smoking, alcohol, self-reported fracture, scoliosis), as independent variables. The results are presented as OR with 95% CI per SD decrease
Significance was defined by a p value < 0.05 and significant values are presented in bold
aSelf-reported from the question “Have you had back pain the past 12 months?